PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medicina Generale 1, Medical Center, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy. aldo.bonaventura@asst-settelaghi.it.\', \'Medicina Generale 1, Medical Center, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy.\', \'Università Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS Ospedale San Raffaele, Milan, Italy.\', \'Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.\', \'Department of Medicine and Surgery, Insubria University, Varese, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00011-022-01540-y
?:hasPublicationType
?:journal
  • Inflammation research : official journal of the European Histamine Research Society ... [et al.]
is ?:pmid of
?:pmid
?:pmid
  • 35113170
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all